Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BMS-986458 |
Trade Name | |
Synonyms | BMS 986458|BMS986458 |
Drug Descriptions |
BMS-986458 is an E3 ubiquitin ligase-dependent BCL6 degrader, which potentially inhibits tumor growth (Blood (2024) 144 (Supplement 1): 957). |
DrugClasses | BCL6 Inhibitor 6 |
CAS Registry Number | NA |
NCIT ID | C202207 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BMS-986458 | BMS-986458 | 0 | 1 |
BMS-986458 + Rituximab | BMS-986458 Rituximab | 0 | 1 |